| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/15/2001 | WO2000068687A3 Methods of identifying therapeutic compounds in a genetically defined setting |
| 02/15/2001 | WO2000068385A3 Novel nucleic acids and proteins with growth hormone activity |
| 02/15/2001 | WO2000068384A3 NOVEL NUCLEIC ACIDS AND PROTEINS WITH p53 ACTIVITY AND ALTERED TETRAMERIZATION DOMAINS |
| 02/15/2001 | WO2000068376B1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same |
| 02/15/2001 | WO2000068370A3 ib00180US MAIS |
| 02/15/2001 | WO2000066709A3 Zymogen activation system |
| 02/15/2001 | WO2000066067A3 Ibd-associated microbial antigens and methods of using same |
| 02/15/2001 | WO2000065054A3 Human membrane-associated proteins |
| 02/15/2001 | WO2000064946A3 Compositions and methods for cancer treatment by selectively inhibiting vegf |
| 02/15/2001 | WO2000063403A3 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein |
| 02/15/2001 | WO2000059933A3 HUMAN MESENCHYMAL DNAs AND EXPRESSION PRODUCTS |
| 02/15/2001 | WO2000058482A3 Transducing phages |
| 02/15/2001 | WO2000057920A3 Method for expressing proteins |
| 02/15/2001 | WO2000057900A3 Factor for regulation of neurite growth |
| 02/15/2001 | WO2000056866A3 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 02/15/2001 | WO2000055346A3 Methods and materials for the rapid and high volume production of a gene knock-out library in an organism |
| 02/15/2001 | WO2000053723A8 Scarecrow gene, promoter and uses thereof |
| 02/15/2001 | WO2000053636A3 Dsp-1 dual-specificity map kinase phosphatase |
| 02/15/2001 | WO2000052173A3 Cloned human sphingosine kinase homologues |
| 02/15/2001 | WO2000052165A3 Compositions and methods for breast cancer therapy and diagnosis |
| 02/15/2001 | WO2000052137A3 Plant ligand-gated ion channels |
| 02/15/2001 | WO2000049416A3 Receptor assay for detecting an effect test compounds have on a particular membrane receptor |
| 02/15/2001 | WO2000049156A3 Lysophosphatidic acid acetyltransferases |
| 02/15/2001 | WO2000049144A3 Pyk2 binding proteins |
| 02/15/2001 | WO2000044908A3 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins |
| 02/15/2001 | WO2000043419A3 Exocytosis pathway proteins and methods of use |
| 02/15/2001 | WO2000032774A8 12216 receptor, a g-protein coupled receptor |
| 02/15/2001 | WO2000032761A8 Ethylene-response-factor1 (erf1) in plants |
| 02/15/2001 | WO2000011204A3 Homer interacting proteins |
| 02/15/2001 | WO1999066079A9 Detection of non-viral organisms with srp rna |
| 02/15/2001 | WO1999057128A8 Optimization of pest resistance genes using dna shuffling |
| 02/15/2001 | WO1999035903A8 METHODS FOR STRAWBERRY TRANSFORMATION USING $i(AGROBACTERIUM TUMEFACIENS) |
| 02/15/2001 | DE19937957A1 Homogentisat-Dioxygenase Homogentisate dioxygenase |
| 02/15/2001 | DE19937846A1 New human gene BOCT, encoding an organic cation transporter, useful for diagnosis, treatment and development of pharmaceuticals |
| 02/15/2001 | DE19937839A1 New human gene OLFXY, encoding an olfactory receptor, useful for diagnosis, treatment and development of pharmaceuticals |
| 02/15/2001 | DE19937607A1 Laboratory robot, useful for automated isolation of nucleic acid, includes orientation device to ensure proper alignment between robotic arm and unit being transported |
| 02/15/2001 | DE19936412A1 DNA-Konstrukte zur Herstellung transgener Pflanzen DNA constructs for producing transgenic plants |
| 02/15/2001 | DE19936003A1 Lentivirus aus der Gruppe der Immunschwächeviren der Drillaffen(mandrillus leucophaeus) und ihre Verwendung Lentivirus from the group of immunodeficiency viruses of the drill monkey (mandrillus leucophaeus) and their use |
| 02/15/2001 | DE19935140A1 Neue Glykosyltransferase, ihre Herstellung und Verwendung New glycosyltransferase, their preparation and use |
| 02/15/2001 | DE19905913C1 Stabilizing double-stranded nucleic acid, useful e.g. in restoring double strands after sterilization, by incubation with histone-like protein from Thermotoga maritima |
| 02/15/2001 | DE10019864A1 Nucleic acid sequences from alkane metabolizing Candida yeast, encoding cytochrome b5 and used for the oxidation of long chain alkyl compounds and for the production of long chain dicarbonic acids |
| 02/15/2001 | CA2419714A1 Direct aspiration-reaction and injection device and methods of use |
| 02/15/2001 | CA2390094A1 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 02/15/2001 | CA2388341A1 Non-human transgenic animals for the study of neurodegenerative syndromes |
| 02/15/2001 | CA2384744A1 Diagnostic method using expression of mn/ca9 protein in agus pap smears |
| 02/15/2001 | CA2383230A1 Tumor-associated antigen (r11) |
| 02/15/2001 | CA2382659A1 Dendritic enriched secreted lymphocyte activation molecule |
| 02/15/2001 | CA2381699A1 Novel methods of diagnosis of angiogenesis compostions and methods of screening for angiogenesis modulators |
| 02/15/2001 | CA2381625A1 Methods for detecting mutations using primer extension |
| 02/15/2001 | CA2381607A1 Glucuronoxylomannan (gxm)-o-acetylhydrolase of cryptococcus neoformans and uses thereof |
| 02/15/2001 | CA2381455A1 Monoclonal antibodies for human cytochrome p450 3a4 and human cytochrome p450 2c9 |
| 02/15/2001 | CA2381396A1 Polynucleotides and polypeptides encoded thereby |
| 02/15/2001 | CA2381325A1 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy |
| 02/15/2001 | CA2381293A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 02/15/2001 | CA2381290A1 Bryostatins, bryopyrans and polyketides: compositions and methods |
| 02/15/2001 | CA2381284A1 Fhm, a novel member of the tnf ligand supergene family |
| 02/15/2001 | CA2381267A1 Transgenic plants expressing photorhabdus toxin |
| 02/15/2001 | CA2381226A1 Method of recording gene analysis data |
| 02/15/2001 | CA2381224A1 Cationic lipid compounds and use thereof for transferring negatively charged substances of therapeutic interest |
| 02/15/2001 | CA2381204A1 Pcr-based detection and quantification of tapesia yallundae and tapesia acuformis |
| 02/15/2001 | CA2381005A1 Therapeutic polypeptides and methods for using same |
| 02/15/2001 | CA2380844A1 Factor x analog with an improved ability to be activated |
| 02/15/2001 | CA2380678A1 Treatment of inflammatory or malignant disease using dnazymes |
| 02/15/2001 | CA2380646A1 Diagnostic method using expression of mn/ca9 protein in ascus pap smears |
| 02/15/2001 | CA2380633A1 Peptide antagonists of factor viia |
| 02/15/2001 | CA2380302A1 Production of proteins by autoproteolytic cleavage |
| 02/15/2001 | CA2379998A1 Soluble, active recombinant human mao-b |
| 02/15/2001 | CA2379608A1 Cancer treatments and diagnostics utilizing rad51 related molecules and methods |
| 02/15/2001 | CA2379166A1 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms instrastrand base pairs |
| 02/15/2001 | CA2379165A1 Chimeric proteins |
| 02/15/2001 | CA2378787A1 Method of making plant artificial chromosomes |
| 02/15/2001 | CA2378292A1 A knockout mouse for the tumor suppressor gene anx7 |
| 02/15/2001 | CA2378032A1 Crystallization and structure determination of staphylococcus aureus udp-n-acetylenolpyruvylglucosamine reductase (s. aureus murb) |
| 02/15/2001 | CA2377422A1 Periodic structures comprising lipids, polyelectrolytes, and structure- inducing soluble oligovalent linkers, and biological use thereof |
| 02/15/2001 | CA2374745A1 Proteases and protease inhibitors |
| 02/15/2001 | CA2373814A1 Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis |
| 02/15/2001 | CA2345028A1 Regulation of embryonic transcription in plants |
| 02/14/2001 | EP1076097A1 METHOD FOR CONTROLLING CLEAVAGE BY OmpT PROTEASE |
| 02/14/2001 | EP1076095A1 Methods for transformation of plants, transformed plants and processes for preparation of polyesters |
| 02/14/2001 | EP1076094A2 Plasmid capable of autonomous replication in coryneform bacteria |
| 02/14/2001 | EP1076093A1 Sakuranetin synthase gene |
| 02/14/2001 | EP1076092A2 Sequences of hepatitis C virus type10 and their use as prophylactic, therapeutic and diagnostic agents |
| 02/14/2001 | EP1076091A1 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
| 02/14/2001 | EP1076089A1 Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders |
| 02/14/2001 | EP1076065A1 Polypeptide having antihuman immunodeficiency virus activity, gene encoding the polypeptide and process for producing the polypeptide |
| 02/14/2001 | EP1075841A1 Pneumococcal vaccines |
| 02/14/2001 | EP1075662A2 Methods for diagnosing and evaluating cancer |
| 02/14/2001 | EP1075551A1 Method for non-radioactive detection of membrane-bonded nucleic acids and test kit |
| 02/14/2001 | EP1075550A1 Method for identifying and representing interindividual differences of dna sequences |
| 02/14/2001 | EP1075548A1 Electrical integrated nucleic acid isolation, purification and detection |
| 02/14/2001 | EP1075546A1 Method and device for isolating nucleic acids |
| 02/14/2001 | EP1075544A1 Chemically modified nucleic acids and methods for coupling nucleic acids to solid support |
| 02/14/2001 | EP1075543A2 Reduced complexity nucleic acid targets and methods of using same |
| 02/14/2001 | EP1075541A1 Electronic detection of nucleic acids using monolayers |
| 02/14/2001 | EP1075540A1 Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| 02/14/2001 | EP1075536A1 Methods for identifying pathways of drug action |
| 02/14/2001 | EP1075532A1 Partially deleted adenoviral vectors |
| 02/14/2001 | EP1075531A1 Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery |
| 02/14/2001 | EP1075530A1 Genomic sequences upstream of the coding region of the g-csf gene for protein production and delivery |
| 02/14/2001 | EP1075529A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |